From the available data, CA125, although widely used in the management of ovarian tumors [26], shows low diagnostic specificity in leiomyosarcomas, with elevated levels observed in various benign conditions or other gynecologic malignancies [15,17]. The gene discussed is MUC16; the disease is ovarian neoplasm.